Exodus Point Capital Management, LP Crispr Therapeutics Ag Transaction History

Exodus Point Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $1.07 Million - $1.57 Million	-17,649 Reduced 51.41%	16,682 $1.14 Million
Q3 2023 Nov 09, 2023	SELL	$45.39 - $59.0 $101,310 - $131,688	-2,232 Reduced 6.1%	34,331 $1.56 Million
Q2 2023 Aug 10, 2023	SELL	$43.47 - $67.77 $706,691 - $1.1 Million	-16,257 Reduced 30.78%	36,563 $2.05 Million
Q1 2023 May 11, 2023	BUY	$41.0 - $56.12 $1.12 Million - $1.54 Million	27,379 Added 107.62%	52,820 $2.39 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $322,180 - $539,873	8,221 Added 47.74%	25,441 $1.03 Million
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $1.05 Million - $1.44 Million	17,220 New	17,220 $1.13 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $825,615 - $1.23 Million	-15,522 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $439,884 - $698,456	6,276 Added 67.88%	15,522 $1.18 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.02 Million - $1.45 Million	9,246 New	9,246 $1.04 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $253,511 - $406,991	-2,514 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $368,476 - $699,013	-3,328 Reduced 56.97%	2,514 $306,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $465,432 - $1.01 Million	5,842 New	5,842 $894,000
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $240,317 - $474,704	-6,242 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $210,230 - $390,312	6,242 New	6,242 $265,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.23B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.